DE855894C - Process for the production of durable, aqueous solutions of gluconates - Google Patents
Process for the production of durable, aqueous solutions of gluconatesInfo
- Publication number
- DE855894C DE855894C DEV2957A DEV0002957A DE855894C DE 855894 C DE855894 C DE 855894C DE V2957 A DEV2957 A DE V2957A DE V0002957 A DEV0002957 A DE V0002957A DE 855894 C DE855894 C DE 855894C
- Authority
- DE
- Germany
- Prior art keywords
- calcium
- gluconates
- durable
- solution
- aqueous solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 4
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 title description 5
- 239000007864 aqueous solution Substances 0.000 title description 5
- FAYYUXPSKDFLEC-UHFFFAOYSA-L calcium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Ca+2].[O-]S([O-])(=O)=S FAYYUXPSKDFLEC-UHFFFAOYSA-L 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 18
- 235000013927 calcium gluconate Nutrition 0.000 description 9
- 229960004494 calcium gluconate Drugs 0.000 description 8
- 239000004227 calcium gluconate Substances 0.000 description 8
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- -1 aliphatic amino alcohols Chemical class 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung haltbarer, wäßriger Lösungen von Gluconaten lekanntl ich werden höherprozentige, wäßrige Lösungen von Calciumgluconaten, worin das Metall in komplexer Bindung vorliegt, zur Therapie verwendet. Da diese übersättigten Lösungen die Neigung zeigen nach einiger Zeit auszukristallisieren hat man die verschiedensten Stabilisatoren zugesetzt, um eine brauchbare Injektionslösung zu erhalten.Process for the preparation of long-lasting, aqueous solutions of gluconates lekonl I will use higher percentage, aqueous solutions of calcium gluconates, in which the metal exists in a complex bond, used for therapy. Because these oversaturated solutions show the tendency to crystallize out after some time one has the most varied Stabilizers added to obtain a usable solution for injection.
Diese Zusätze sind aber für die Therapie nicht nur wertlose P)allastsioffe. sondern beeinträchtigen zudem noch die Verträglichkeit.However, these additives are not only worthless substances for therapy. but also affect the tolerance.
Es wurde gefunden+, daß Calciumthiosulfat zur Darstellung solcher übersättigten und haltbaren Lösungen als Stal)ilisator von besonderem Vorteil ist. Denn außer der Eigenschaft, die Auskristallisation des Gluconates aus den übersättigten Lösung gen zu verhindern, hat bekann,tlich Calciumthiosulfat noch zusätzlich die erwünschte Fähigkeit, Schwermetalle zu entgiften. Dieser neue Stabilisator ist somit kein 13allaststoff, sondern besitzt zudem noch eine therapeutische Verwertbarkeit. Weiter kommt hinzu, daß die mit Calciumthiosulfat stabilisierte Calciumgluconatlösung noch zusätzlich eine Erhöhung des Calciumgehaltes erfährt, was für die Therapie von besonderem Vorteil ist. It has been found + that calcium thiosulfate to represent such supersaturated and durable solutions as a stabilizer is of particular advantage. Because apart from the property, the crystallization of the gluconate from the oversaturated To prevent the solution, calcium thiosulphate has additionally been known Desired ability to detoxify heavy metals. This new stabilizer is thus not a fiber, but also has a therapeutic utility. In addition, the calcium gluconate solution stabilized with calcium thiosulfate an additional increase in the calcium content is experienced, which is beneficial for the therapy is of particular advantage.
In den neuen haltbaren und hochprozentigen wäßrigen Lösungen liegen die Calciumverbindungen in Form von Doppel- bzw. Komplexverbindungen der Gluconate mit Thiosulfat vor. Am besten ist das Verhältnis Mol auf Mol, doch kann zur Erreichung einer solchen Lösung die eine oder andere Kompo nente auch im Überschuß zugegeben werden. In the new durable and high-percentage aqueous solutions lie the calcium compounds in the form of double or complex compounds of the gluconates with thiosulfate. The mole-to-mole ratio is best, but it can help such a solution one or the other component is also added in excess will.
Außer dem Calciumgluconat bzw. seinem basischen Salz hat sich auch das entsprechende Strom tium-, Eisen-, Kakodyleisengluconat geeignet gezeigt. Besides the calcium gluconate or its basic salt it has also the corresponding stream tium, iron, kakodyle iron gluconate shown suitable.
Zur Darstellung der Lösungen kann man so vorgehen, daß man in die wäßrige Calciumthiosulfatlösung die entsprechenldle Menge Calciumgluconat zugibt oder auch umgekehrt. Man kann ebenso auch die beiden Komponenten mischen oder das Doppelsalz nehmen und nachträglich das entsprechende Volumen Wasser zugeben. Geringe Mengen von aliphatischen Aminoalkoholen, wie z. B. Diäthylamino alkohol, Aminoäthanol, Di- bzw. Triäthanolamin, D iäthylaminoi sopentanol usw., diesen wäßrigen Gluconatlösungen zugesetzt, unterstütlzen die Haltbarkeit. Die neuen Lösungen können sterilisiert werden und sind zur Injektion gut geeignet. To represent the solutions, one can proceed in such a way that one enters the aqueous calcium thiosulphate solution the corresponding amount of calcium gluconate admits or vice versa. You can also mix the two components or that Take the double salt and then add the appropriate volume of water. Low Amounts of aliphatic amino alcohols, such as. B. diethylamino alcohol, aminoethanol, Di- or triethanolamine, D iäthylaminoi sopentanol, etc., these aqueous gluconate solutions added, support the shelf life. The new solutions can be sterilized and are well suited for injection.
Beispiel I I,2 g Calciumgluconat und I g Calciumthiosulfat werden auf 10 ccm mit Wasser unter Erwärmen aufgefüllt, wobei eine klare Lösung eintritt. Zur Isolierung des Doppelsalzes wird im Vakuum auf das halbe Volumen eingedampft und mit abs. Alkohol das Doppelsalz ausgefällt. Es stellt ein weißes Pulver dar, das 15 O/o Ca in Form des Calciumthiosulfates und I00/o in Form des Calciumgluconates enthält. Example I I, 2 g calcium gluconate and 1 g calcium thiosulfate made up to 10 ccm with water while warming, whereby a clear solution occurs. To isolate the double salt, it is evaporated to half its volume in vacuo and with abs. Alcohol precipitated the double salt. It is a white powder 15% Ca in the form of calcium thiosulphate and 100% in the form of calcium gluconate contains.
Es ist in Wasser mit neutraler Reaktion gut löslich.It is readily soluble in water with a neutral reaction.
Beispiel 2 In 10 ccm einer Ioo/oigen wäßrigen Calciumthiosuglfatllösung werden I g Calciumgluconat unter Erwärmen gelöst. Die farblose Lösung scheidet auch nach dem Abkühlen und monatelangem Stehen keine Kristalle aus, während die gleiche Lösung aber ohne Calciumthiosulfat schon nach einigen Tagen eine starke Kristallahscheidung ergab. Man kann die neue Lösung sterilisieren. Das l)lf liegt im neutralen Bereich. Example 2 In 10 cc of 100% aqueous calcium thiosulfate solution I g of calcium gluconate are dissolved with warming. The colorless solution also separates no crystals after cooling and standing for months, while the same Solution but without calcium thiosulphate a strong crystal separation after a few days revealed. The new solution can be sterilized. The l) lf is in the neutral area.
Gibt man zur obigen Lösung noch z. B. 0,05 g Diäthylaminoäthylalkohol, so trägt dieses weiter zur Stabiylisierung bei. If you add z. B. 0.05 g diethylaminoethyl alcohol, this further contributes to stabilization.
Beispiel 3 1 g Calciumthiosulfat, I g Calciumgluconat und 8 ccm Wasser werden zusammen bis zur klaren Lösung erhitzt. Man erhält eine klare, haltbare Lösung von neutralem pn. Example 3 1 g of calcium thiosulphate, 1 g of calcium gluconate and 8 cc of water are heated together until the solution is clear. A clear, stable solution is obtained of neutral pn.
An Stelle des Calciumgluconates kann man auch Strontium- und Eisengluconat verwenden. Strontium and iron gluconate can also be used in place of calcium gluconate use.
PATENTANSPRUCE;I I. Verfahren zur Darstellung von haltbaren, wäßrigen Lösungen von Gluconaten, dadurch gekennzeichnet, daß man die Gluconate in Form ihrer Doppel- oder Komplexsalze oder ihrer Gemische mit Calciumthiosulfat in Lösung bringt. PATENT CLAIM; I I. Process for the preparation of durable, aqueous Solutions of gluconates, characterized in that the gluconates are in the form of their Brings double or complex salts or their mixtures with calcium thiosulfate in solution.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEV2957A DE855894C (en) | 1950-12-12 | 1950-12-12 | Process for the production of durable, aqueous solutions of gluconates |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEV2957A DE855894C (en) | 1950-12-12 | 1950-12-12 | Process for the production of durable, aqueous solutions of gluconates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE855894C true DE855894C (en) | 1952-11-17 |
Family
ID=7570231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEV2957A Expired DE855894C (en) | 1950-12-12 | 1950-12-12 | Process for the production of durable, aqueous solutions of gluconates |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE855894C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1195864B (en) * | 1954-06-05 | 1965-07-01 | Siemens Ag | Circuit for a voltage main value meter |
-
1950
- 1950-12-12 DE DEV2957A patent/DE855894C/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1195864B (en) * | 1954-06-05 | 1965-07-01 | Siemens Ag | Circuit for a voltage main value meter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE855894C (en) | Process for the production of durable, aqueous solutions of gluconates | |
| DE977478C (en) | Process for the manufacture of injectable insulin preparations with delayed action | |
| DE726635C (en) | Process for the production of rich, durable solutions of calcium gluconate or lactate | |
| DE731086C (en) | Process for the preparation of durable solutions of calcium gluconate or lactate | |
| DE964632C (en) | Process for the production of colourfast, durable streptomycin solutions of high effectiveness | |
| DE469788C (en) | Process for the preparation of durable calcium-containing solutions of theophylline suitable for injection purposes | |
| DE903624C (en) | Process for the preparation of durable, injectable solutions of 1-phenyl-2, 3-dialkyl-4-dialkylamino-5-pyrazolones | |
| DE882477C (en) | Process for the production of solid and liquid organic sulfur and iodine sulfur preparations | |
| DE263455C (en) | ||
| DE687250C (en) | Process for the preparation of primary and secondary adipic acid hexamethylenetetramine | |
| DE711635C (en) | Process for stabilizing solutions of the circulatory hormone kallikrein from pancreas | |
| AT220599B (en) | Process for the production of a highly concentrated solution of stannous fluorate or of solid stannous fluorate therefrom | |
| AT67793B (en) | Process for the direct preparation of anhydrous and durable hydrosulfites from hydrosulfite solutions. | |
| AT267759B (en) | Process for stabilizing aqueous solutions of iodine-alkali iodide and / or iodine-ammonium iodide | |
| DE670768C (en) | Process for the production of a bath salt suitable for the preparation of solar baths | |
| DE289001C (en) | ||
| DE550439C (en) | Process for the production of durable, saturated calcium gluconate solutions | |
| DE531009C (en) | Process for the preparation of compounds of the higher homologues of polyoxybenzenes | |
| AT216486B (en) | Process for the preparation of new mercaptoacylamides | |
| DE431580C (en) | Representation of aurosodium thiosulfate | |
| DE378892C (en) | Process for the production of tartar | |
| DE574971C (en) | Process for the preparation of solutions of silk fibroin using solutions of hydrated salts | |
| DE671747C (en) | Process for the production of durable, viscous, acidic rhodanide solutions | |
| AT151971B (en) | Process for the preparation of n-hexylresorcinol sulfonic acid and its salts. | |
| AT205669B (en) |